Naloxegol Oxalate Patent Expiration
Naloxegol Oxalate is Used for managing constipation caused by opioid medications. It was first introduced by Valinor Pharma Llc
Naloxegol Oxalate Patents
Given below is the list of patents protecting Naloxegol Oxalate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Movantik | US9012469 | Crystalline naloxol-peg conjugate | Apr 02, 2032 | Valinor |
Movantik | US7786133 | Chemically modified small molecules | Sep 16, 2028 | Valinor |
Movantik | US8067431 | Chemically modified small molecules |
Dec 16, 2024
(Expired) | Valinor |
Movantik | US7056500 | Polymer conjugates of opioid antagonists |
Jun 29, 2024
(Expired) | Valinor |
Movantik | US7662365 | Polymer conjugates of opioid antagonists |
Oct 18, 2022
(Expired) | Valinor |
Movantik | US8617530 | Polymer conjugates of opioid antagonists |
Oct 18, 2022
(Expired) | Valinor |
Naloxegol Oxalate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List